Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47M Buy
66,369
+2,335
+4% +$156K 0.37% 63
2026
Q1
$4.02M Buy
64,034
+9,546
+18% +$665K 0.36% 66
2025
Q4
$3.62M Sell
54,488
-4,903
-8% -$317K 0.31% 70
2025
Q3
$4M Sell
59,391
-95
-0.2% -$7.52K 0.35% 66
2025
Q2
$5.19M Buy
59,486
+2,425
+4% +$190K 0.48% 59
2025
Q1
$3.9M Buy
57,061
+1,167
+2% +$95.2K 0.38% 65
2024
Q4
$4.35M Sell
55,894
-5,233
-9% -$387K 0.42% 63
2024
Q3
$4.1M Buy
61,127
+27,246
+80% +$2.24M 0.39% 67
2024
Q2
$3.84M Buy
33,881
+880
+3% +$111K 0.39% 64
2024
Q1
$4.58M Buy
33,001
+2,245
+7% +$282K 0.47% 58
2023
Q4
$3.82M Buy
30,756
+9,970
+48% +$1.02M 0.44% 62
2023
Q3
$1.94M Buy
20,786
+12,616
+154% +$1.42M 0.24% 79
2023
Q2
$1.05M Buy
+8,170
New +$988K 0.12% 97

Other funds holding DXCM

Woodstock Corp's DXCM Position: Q2 2026 in Review

Woodstock Corp increased its DexCom (DXCM) stake by 3.6% in Q2 2026, buying an estimated $156K and bringing the position to 66,369 shares worth $4.47M. The position accounts for 0.37% of the portfolio, ranked #63.

Woodstock Corp first reported a position in DXCM in Q2 2023 and has held it in 13 quarters since. The position peaked at $5.19M in Q2 2025. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Woodstock Corp held 66,369 shares of DexCom worth $4.47M as of Q2 2026.
  • Woodstock Corp bought 2,335 DexCom shares in Q2 2026, an estimated $156K.
  • DexCom made up 0.37% of Woodstock Corp's portfolio in Q2 2026, its #63 holding.
  • Woodstock Corp first reported a position in DexCom in Q2 2023 and has held it in 13 quarters since.
  • Woodstock Corp's DexCom position peaked at $5.19M in Q2 2025.
  • 971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Woodstock Corp's 13F filing for Q2 2026, filed 13 Jul 2026.